Herbal Medicines Demonstrate Potency Against Bartonella, a Disease-causing Pathogen, According to New Lab Study

Herbal Medicines Demonstrate Potency Against Bartonella

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Herbal Medicines Demonstrate Potency Against Bartonella, a Disease-causing Pathogen, According to New Lab Study

Three of these herbal medicines also have high potency against Borrelia burgdorferi, the bacterium that causes Lyme disease, and Babesia duncani, according to previous lab studies also funded by Bay Area Lyme Foundation

PORTOLA VALLEY, CA, August 5, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data showing that herbal medicines have potent activity in test tubes compared to pharmaceuticals commonly-prescribed for the treatment of Bartonella henselae, a bacterium believed  to be carried by ticks and the cause of cat scratch fever. This is the first study to find antimicrobial activity of some of these herbal medicines. Published in the journal Infectious Microbes & Diseases, the laboratory study was funded in part by the Bay Area Lyme Foundation.

“With increasing rates of tick-borne diseases and a consistent concern about the overuse of antibiotics, this early research of herbals is extremely exciting,” said Linda Giampa, executive director, Bay Area Lyme Foundation. “We are hopeful that future pre-clinical and clinical studies will continue to show that herbals have the same effectiveness as this study and other recently-published studies.”

Our Most Recent Tick Ecology Studies and What We’ve Discovered

Ticktective Podcasts

Dan Salkeld, PhD

Dan Salkeld, PhD, Bay Area Lyme Scientific Advisory Board member, is a Research Scientist in the Department of Biology at Colorado State University, and tick researcher extraordinaire. He discusses the ecology and epidemiology of Lyme and other emerging tick-borne pathogens such as Borrelia miyamotoi. Ticktective Video and Podcast Editor: Kiva Schweig.

 

, .

Bay Area Lyme Foundation Partners with American Junior Golf Association to Provide Critical Education About Tick-borne Disease

Golfers are at high risk for Lyme disease

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Partners with American Junior Golf Association to Provide Critical Education About Tick-borne Disease

Golf is Estimated to Be Among the Highest Risk Sports for Contracting Lyme and Other Tick-borne Diseases

Portola Valley, CA, July 15, 2021 — Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, and the American Junior Golf Association have announced a new partnership aimed at educating young golfers about Lyme disease and providing tips for preventing tick bites. For this partnership, Bay Area Lyme Foundation will provide prevention materials, tick removal keys, Tick Tock Naturals® organic tick repellent and Sawyer® picaridin lotion to all AJGA members. In addition, Bay Area Lyme Foundation will become a Leadership Links charity partner, and two tournaments will be named for the Foundation by the end of 2023.

“As former AJGA and Harvard Division 1 golfers, my brother and I wish we had been educated on the risks associated with Lyme disease and the prevalence of ticks throughout the U.S., and ways to prevent being bitten,” said Nina Fairbairn (AJGA ’13, Harvard ’17), an investment partner who volunteers for Bay Area Lyme Foundation as an Advisory Board member and is spearheading this partnership for the Foundation. “Few golfers seem aware of the risks and even fewer take precautions, and it’s imperative for us to change this.”

Golf courses are a hotbed for ticks that can carry Lyme disease. Ticks flourish in areas between woods and open spaces, which is the exact terrain of golf courses, and live on the small forest animals that often occupy golf courses. Lyme disease is the most common vector borne illness in the United States with at least 476,000 new cases each year.

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

2021 Emerging Leader Awards

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

Brandon Jutras, PhD of Virginia Tech, Nitya Ramadoss, PhD of Stanford University and Michael P. Rout, PhD of The Rockefeller University are this year’s recipients

PORTOLA VALLEY, Calif., July 6th, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the recipients of the 2021 Emerging Leader Awards (ELA), which are designed to support promising scientists who represent the future of Lyme disease research leadership. Michael P. Rout, PhD of The Rockefeller University will receive $250,000 for his work with nanobodies to develop a sensitive point-of-care diagnostic. Brandon Jutras, PhD of Virginia Tech and Nitya Ramadoss, PhD of Stanford University will each receive $100,000 toward the development of a novel direct-detection diagnostic approach for Lyme disease and a novel therapeutic based on B-cell mapping, respectively. Lyme disease is a potentially disabling infection diagnosed in nearly half a million Americans each year.

“As there is not a diagnosis or treatment that works for all patients, there is a critical need to develop direct-detection diagnostics as well as treatments that can prevent the development of persistent Lyme disease, and we are excited to support these novel approaches that have shown success in other areas,” said Linda Giampa, executive director, Bay Area Lyme Foundation.

Two of the award winners will utilize biological samples from the Lyme Disease Biobank, a program of the Bay Area Lyme Foundation, to collect well-characterized human tissue, blood and urine specimens to accelerate research of Lyme disease and other tick-borne infections.

The Mysterious History of Tick-borne Diseases and How We Can Stem the Epidemic

Kris Newby

Kris Newby, author of Bitten: The Secret History of Lyme Disease and Biological Weapons, senior producer of the Lyme disease documentary, Under Our Skin, discusses her Lyme history, her extensive research into tick-borne diseases in the USA and where we find ourselves today in this new pandemic world. Ticktective Video and Podcast Editor: Kiva Schweig.

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

Ticks Carrying Disease Found to Be Abundant in Beach Areas

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

 

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

Study Funded by Bay Area Lyme Foundation Also Shows Ticks in Northern California Carry a Diversity of Disease-causing Bacteria at Higher Rates Than Previously Reported

Portola Valley, CA, April 23, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a study demonstrating that adult Western black-legged ticks (Ixodes pacificus) carrying Borrelia burgdorferi, the bacterium that causes Lyme disease, were found in beach areas at equal rates to the woodland habitats in parts of northwestern California. Further, researchers, who were testing ticks for up to 5 species of tick-borne bacteria, found that the collective infection rate of all species was as high as 31% in at least one area, which offers a different perspective from previous studies that tested for a single species of bacteria in a specific area or areas. Conducted by researchers at Colorado State University, Northern Arizona State University and Translational Genomics Research Institute (TGen), and published in the June issue of the peer-reviewed journal Applied and Environmental Microbiology (AEM), the research points to the need for greater education for both the community at large and healthcare providers about the risks of tick-borne disease.

“The high rate of disease-carrying ticks in the coastal chaparral was really surprising to us. And when looking at all the tick-borne pathogens simultaneously, it makes you rethink the local disease risk,” said Lead Author Daniel Salkeld, PhD, Colorado State University. “Previously, we, along with other researchers, may have missed the big picture when we focused our attention on investigating the risk of one pathogen at a time. Now, we have a new imperative to look at the collective risk of all tick-borne pathogens in an area.”

First Female US Air Force Thunderbird Pilot and Her Fiercest Battle Yet

Ticktective Podcasts

Col. Nicole Malachowski

Col. Nicole Malachowski, first female Thunderbird pilot, National Women’s Hall of Famer, and Former Deputy Director for US Air Force Readiness and Training for the Office of the Under Secretary of Defense for Personnel and Readiness, and Bay Area Lyme Foundation Ambassador shares her challenging journey from military fighter to Lyme warrior. Ticktective Video and Podcast Editor: Kiva Schweig.

Proof of Persistent Lyme

Ticktective Podcasts

Monica Embers, PhD

Monica Embers, PhD, Associate Professor of Microbiology and Immunology at the Tulane National Primate Research Center and Bay Area Lyme Scientific Advisory Board member discusses xenodiagnosis, Borrelia persistence, and her ongoing research in non-human primates. Ticktective Video and Podcast Editor: Kiva Schweig.

Finding Strength and Positivity Through Hardship

Allyshia Gupta

Miss California USA 2020 and Bay Area Lyme Ambassador, Allyshia Gupta, shares her personal story of finding herself through hardship and loss, and the importance of service as a source of strength. Ticktective Video and Podcast Editor: Kiva Schweig.

Nanotrap® Urine Test for Lyme Borreliosis

– Wendy Adams, Research Grant Director, Bay Area Lyme Foundation

 

Bay Area Lyme has a goal to leverage the entrepreneurial spirit and innovation of Silicon Valley in order to catalyze novel projects around the country. Our belief is that the application of cutting-edge technologies will have a dramatic impact on making Lyme disease easy to diagnose and simple to cure. We collaborate with world-class scientists focused on Lyme projects which leverage knowledge from other fields of medicine and research. We also prioritize engagement with the investment and biotech communities so that breakthroughs in the laboratory can be translated more quickly to patients. Since our inception, our scientific research funding priorities have been focused on supporting diagnostic and therapeutic projects.

It is impossible to cure Lyme disease in every case without understanding how to diagnose it accurately. There are many reasons for this disease being difficult to identify—ticks are tiny, the EM skin rash is often misdiagnosed and symptoms overlap with other acute diseases like influenza. Most importantly, the widely used two tier diagnostic testing required for Lyme disease is currently the ELISA and Western Blot, which only detects the immune response (indirect detection) and not the pathogen itself. Because it can take at least 2-4 weeks for the body to generate antibodies, these tests have been shown to miss up to 70% of acute Lyme cases. These tests also do not detect other related Borrelia species, such as Borrelia miyamotoi), and cannot determine when the infection is eradicated.